Net loss for the first quarter of 2012 was $1.3 million, compared to $1.9 million net loss during the first quarter of 2011. Cash and cash equivalents decreased $3.8 million over the fourth quarter of 2011, reflecting a payment of $5 million to Cross Medical as part of an agreement.
United States revenues were reported as $32.6 million, slightly less than the first quarter of 2011. U.S. hospital sales grew 3 percent, which was driven by biologics and minimally invasive products. International revenue was flat from last year to this year. Company CEO and Chairman Les Cross attributes the decreases to a challenging spine market.
More Articles on Spine Devices:
VG Innovations Receives Patent for Spinal Facet Fusion System
CEO of Spine Network of California Faces Fraud Charges
15 Spine Deice Company Leadership Moves
Alphatec Spine Q1 Revenue Down, U.S. Hospital Business Grows FeaturedWritten by Laura Miller | May 09, 2012
Alphatec Spine reported first quarter revenue of $48.5 million, slightly less than the same period last year.
© Copyright ASC COMMUNICATIONS 2011. Interested in LINKING to or REPRINTING this content? View our policies here.